UroGen Pharma Ltd. (URGN) Total liabilities 2016–2025
UroGen Pharma Ltd. (URGN) total liabilities at each fiscal year-end, per SEC filings.
$305.9MFY2025 · since FY2016: $6.7M → $305.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $305.9M | +3.9% |
| FY2024 | $294.5M | +20.9% |
| FY2023 | $243.5M | +8.2% |
| FY2022 | $225.0M | +102.1% |
| FY2021 | $111.3M | +334.0% |
| FY2020 | $25.6M | +16.1% |
| FY2019 | $22.1M | +64.0% |
| FY2018 | $13.5M | +91.4% |
| FY2017 | $7.0M | +4.2% |
| FY2016 | $6.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice